Case Report

COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case

Volume: 17 Number: 4 July 25, 2023
TR EN

COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case

Abstract

Immune thrombocytopenic purpura (ITP) is a hematological disease manifested by isolated thrombocytopenia. Viral infections in the last month are often found in its etiology. After COVID-19 infection, various hematological complications can be seen, as well as the development of ITP. In this article, a case of pediatric acute ITP who was diagnosed during COVID-19 infection and had no signs of bleeding is presented.

Keywords

References

  1. Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. Intercontinental Childhood ITP Study Group; Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143:605-8.
  2. Zeller B, Rajantie J, Hedlund-Treutiger I, Tedgård U, Wesenberg F, Jonsson OG, et al. NOPHO ITP. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005;94:178-4.
  3. Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E. Immune Thrombocytopenic Purpura in a Patient with Covid-19. N Engl J Med 2020;382:e43.
  4. Lévesque V, Millaire É, Corsilli D, Rioux-Massé B, Carrier FM. Severe immune thrombocytopenic purpura in critical COVID-19. Int J Hematol 2020;112:746-50.
  5. Bomhof G, Mutsaers PGNJ, Leebeek FWG, Te Boekhorst PAW, Hofland J, Croles FN, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol 2020;190:e61-4.
  6. D’Orazio JA, Neely J, Farhoudi N. ITP in children: pathophysiology and current treatment approaches. J Pediatr Hematol Oncol 2013;35:1-13.
  7. O’Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, et al. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics 2012;129:248-55.
  8. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.

Details

Primary Language

English

Subjects

​Internal Diseases

Journal Section

Case Report

Early Pub Date

May 3, 2023

Publication Date

July 25, 2023

Submission Date

May 10, 2022

Acceptance Date

September 14, 2022

Published in Issue

Year 2023 Volume: 17 Number: 4

APA
Güneş, Ö., Güney, A. Y., Güder, L., Mustafaoğlu, Ö., Bayraktar, P., Şahin, S., Kanık Yüksek, S., Gülhan, B., Bayhan, G. İ., & Özkaya Parlakay, A. (2023). COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case. Türkiye Çocuk Hastalıkları Dergisi, 17(4), 324-327. https://doi.org/10.12956/tchd.1113184
AMA
1.Güneş Ö, Güney AY, Güder L, et al. COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case. Turkish J Pediatr Dis. 2023;17(4):324-327. doi:10.12956/tchd.1113184
Chicago
Güneş, Ömer, Ahmet Yasin Güney, Latife Güder, et al. 2023. “COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case”. Türkiye Çocuk Hastalıkları Dergisi 17 (4): 324-27. https://doi.org/10.12956/tchd.1113184.
EndNote
Güneş Ö, Güney AY, Güder L, Mustafaoğlu Ö, Bayraktar P, Şahin S, Kanık Yüksek S, Gülhan B, Bayhan Gİ, Özkaya Parlakay A (July 1, 2023) COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case. Türkiye Çocuk Hastalıkları Dergisi 17 4 324–327.
IEEE
[1]Ö. Güneş et al., “COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case”, Turkish J Pediatr Dis, vol. 17, no. 4, pp. 324–327, July 2023, doi: 10.12956/tchd.1113184.
ISNAD
Güneş, Ömer - Güney, Ahmet Yasin - Güder, Latife - Mustafaoğlu, Özlem - Bayraktar, Pınar - Şahin, Seda - Kanık Yüksek, Saliha - Gülhan, Belgin - Bayhan, Gülsüm İclal - Özkaya Parlakay, Aslınur. “COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case”. Türkiye Çocuk Hastalıkları Dergisi 17/4 (July 1, 2023): 324-327. https://doi.org/10.12956/tchd.1113184.
JAMA
1.Güneş Ö, Güney AY, Güder L, Mustafaoğlu Ö, Bayraktar P, Şahin S, Kanık Yüksek S, Gülhan B, Bayhan Gİ, Özkaya Parlakay A. COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case. Turkish J Pediatr Dis. 2023;17:324–327.
MLA
Güneş, Ömer, et al. “COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case”. Türkiye Çocuk Hastalıkları Dergisi, vol. 17, no. 4, July 2023, pp. 324-7, doi:10.12956/tchd.1113184.
Vancouver
1.Ömer Güneş, Ahmet Yasin Güney, Latife Güder, Özlem Mustafaoğlu, Pınar Bayraktar, Seda Şahin, Saliha Kanık Yüksek, Belgin Gülhan, Gülsüm İclal Bayhan, Aslınur Özkaya Parlakay. COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case. Turkish J Pediatr Dis. 2023 Jul. 1;17(4):324-7. doi:10.12956/tchd.1113184


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.